当前位置：首页 SCI期刊 SCIE期刊医学中科院4区 JCRQ2 期刊介绍(非官网)

Journal Of Cardiovascular PharmacologySCIE

国际简称：J CARDIOVASC PHARM 参考译名：心血管药理学杂志

中科院分区
4区
CiteScore分区
Q2
JCR分区
Q2

基本信息：: ISSN：0160-2446; E-ISSN：1533-4023; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：UNITED STATES; 出版商：Lippincott Williams and Wilkins Ltd.; 出版语言：English; 出版周期：Monthly; 出版年份：1979; 研究方向：心血管系统-医学

评价信息：: 影响因子：2.6; H-index：91; CiteScore指数：5.1; SJR指数：0.61; SNIP指数：0.504

发文数据：: Gold OA文章占比：14.35%; 研究类文章占比：75.27%; 年发文量：93; 自引率：0.0333...; 开源占比：0.1245; 出版撤稿占比：0.0163...; 出版国人文章占比：0.31; OA被引用占比：0.0977...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Journal Of Cardiovascular Pharmacology期刊介绍

Journal of Cardiovascular Pharmacology is a peer reviewed, multidisciplinary journal that publishes original articles and pertinent review articles on basic and clinical aspects of cardiovascular pharmacology. The Journal encourages submission in all aspects of cardiovascular pharmacology/medicine including, but not limited to: stroke, kidney disease, lipid disorders, diabetes, systemic and pulmonary hypertension, cancer angiogenesis, neural and hormonal control of the circulation, sepsis, neurodegenerative diseases with a vascular component, cardiac and vascular remodeling, heart failure, angina, anticoagulants/antiplatelet agents, drugs/agents that affect vascular smooth muscle, and arrhythmias.

Appropriate subjects include new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects, application of drugs to gain novel insights into physiology or pathological conditions, clinical results with new and established agents, and novel methods. The focus is on pharmacology in its broadest applications, incorporating not only traditional approaches, but new approaches to the development of pharmacological agents and the prevention and treatment of cardiovascular diseases. Please note that JCVP does not publish work based on biological extracts of mixed and uncertain chemical composition or unknown concentration.

期刊简介Journal Of Cardiovascular Pharmacology期刊介绍

《Journal Of Cardiovascular Pharmacology》自1979出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：约1月
医学
CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
中科院4区
非预警

Cite Score数据（2024年最新版）Journal Of Cardiovascular Pharmacology Cite Score数据

CiteScore：5.1
SJR：0.61
SNIP：0.504

学科类别	分区	排名	百分位
大类：Medicine 小类：Cardiology and Cardiovascular Medicine	Q2	114 / 387	70%
大类：Medicine 小类：Pharmacology	Q2	150 / 313	52%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Journal Of Cardiovascular Pharmacology 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	4区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学	4区 4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Journal Of Cardiovascular Pharmacology JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	84 / 220	62%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	173 / 354	51.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	88 / 220	60.23%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	168 / 354	52.68%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
CHINA MAINLAND149
USA90
Italy23
Japan20
GERMANY (FED REP GER)19
Brazil11
France11
Canada10
Netherlands10
England9

本刊中国学者近年发表论文

1、Efficacy and Safety of Finerenone for Prevention of Cardiovascular Events in Type 2 Diabetes Mellitus With Chronic Kidney Disease: A Meta-analysis of Randomized Controlled Trials
Author: Yang, Shuai; Shen, Wen; Zhang, Hong-zhou; Wang, Chen-xi; Yu, Wan-qian; Wu, Qing-hua

Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 55-62. DOI: 10.1097/FJC.0000000000001364
2、Mechanisms of SGLT2 Inhibitors in Heart Failure and Their Clinical Value
Author: Xie, Yafei; Wei, Yujie; Li, Dan; Pu, Jie; Ding, Hong; Zhang, Xiaowei

Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 4-14. DOI: 10.1097/FJC.0000000000001380
3、Effects of Recombinant Human Brain Natriuretic Peptide on Atrial Fibrillation After Coronary Artery Bypass Grafting
Author: Wei, Yangyan; Zhang, Qian; Chi, Honghui; Wang, Ziyao; Chang, Qing

Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 63-69. DOI: 10.1097/FJC.0000000000001370
4、Salidroside Regulates Mitochondrial Homeostasis After Polarization of RAW264.7 Macrophages
Author: Wang, Xiu-Long; Sun, Rui-Xiang; Li, Dong-Xu; Chen, Zhi-Gang; Li, Xue-Fang; Sun, Si-Yu; Lin, Fei; Zhao, Guo-An

Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 85-92. DOI: 10.1097/FJC.0000000000001362
5、Silencing of Long Noncoding RNA TUG1 Ameliorates Atherosclerosis-Induced Myocardial Injury by Upregulating microRNA-30b-3p and Downregulating Brd4
Author: Li, De-long; Zheng, Bin-bin; Zeng, Xin; Li, Jiahua; Dai, Ruo-zhu

Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 45-54. DOI: 10.1097/FJC.0000000000001367
6、Feedback Interaction Between Apelin and Endoplasmic Reticulum Stress in the Rat Myocardium
Author: Jin, Sheng; Wang, Yipu; Ma, Liuchang; Zhang, Jiaqi; Huang, Panna; Zhang, Haozhe; Liu, Xinxia; Wu, Yuming; Wang, Xiaoning; Teng, Xu

Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 1, pp. 21-34. DOI: 10.1097/FJC.0000000000001369
7、Renal Safety of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials
Author: Zheng, Shaohua; Zhang, Yujiao; Gu, Lei; Ma, Kai; Wang, Xuehan; Hou, Yinglong; Zhang, Fenglei; Gao, Mei

Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 2, pp. 93-103. DOI: 10.1097/FJC.0000000000001379
8、Effect of Dexmedetomidine on Cardiac Surgery Patients
Author: Xiao, Man; Jiang, Chong-Fa; Gao, Qin; Pan, Jue; Zhang, Hong; Wu, Sheng-Nan; Dou, Mao-Sen

Journal: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2023; Vol. 81, Issue 2, pp. 104-113. DOI: 10.1097/FJC.0000000000001384